Susquehanna International Group’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-671,400
| Closed | -$4.05M | – | 11347 |
|
|
2019
Q4 | $4.05M | Buy |
671,400
+621,500
| +1,245% | +$3.6M | ﹤0.01% | 3274 |
|
|
2019
Q3 | $180K | Buy |
+49,900
| New | +$192K | ﹤0.01% | 9200 |
|
|
2018
Q4 | – | Sell |
-34,100
| Closed | -$125K | – | 10466 |
|
|
2018
Q3 | $125K | Buy |
34,100
+2,300
| +7% | +$6.86K | ﹤0.01% | 8513 |
|
|
2018
Q2 | $90K | Sell |
31,800
-4,900
| -13% | -$16.7K | ﹤0.01% | 9082 |
|
|
2018
Q1 | $136K | Sell |
36,700
-44,500
| -55% | -$146K | ﹤0.01% | 8576 |
|
|
2017
Q4 | $234K | Buy |
81,200
+14,500
| +22% | +$52.7K | ﹤0.01% | 8000 |
|
|
2017
Q3 | $299K | Sell |
66,700
-24,500
| -27% | -$109K | ﹤0.01% | 7405 |
|
|
2017
Q2 | $419K | Buy |
91,200
+39,200
| +75% | +$158K | ﹤0.01% | 6975 |
|
|
2017
Q1 | $219K | Sell |
52,000
-115,300
| -69% | -$479K | ﹤0.01% | 7874 |
|
|
2016
Q4 | $691K | Sell |
167,300
-21,600
| -11% | -$115K | ﹤0.01% | 6307 |
|
|
2016
Q3 | $1.53M | Sell |
188,900
-9,300
| -5% | -$79.1K | ﹤0.01% | 4004 |
|
|
2016
Q2 | $1.55M | Sell |
198,200
-72,700
| -27% | -$624K | ﹤0.01% | 4031 |
|
|
2016
Q1 | $2.09M | Sell |
270,900
-816,400
| -75% | -$5.98M | ﹤0.01% | 3684 |
|
|
2015
Q4 | $11.7M | Sell |
1,087,300
-279,100
| -20% | -$2.54M | 0.01% | 1611 |
|
|
2015
Q3 | $9.44M | Sell |
1,366,400
-79,000
| -5% | -$644K | ﹤0.01% | 1897 |
|
|
2015
Q2 | $12.8M | Buy |
1,445,400
+121,900
| +9% | +$1.15M | 0.01% | 1726 |
|
|
2015
Q1 | $13.1M | Sell |
1,323,500
-990,900
| -43% | -$12.4M | 0.01% | 1616 |
|
|
2014
Q4 | $28.4M | Sell |
2,314,400
-373,600
| -14% | -$4.56M | 0.01% | 1073 |
|
|
2014
Q3 | $26.8M | Buy |
2,688,000
+1,823,400
| +211% | +$16.9M | 0.01% | 1155 |
|
|
2014
Q2 | $6.54M | Buy |
864,600
+401,500
| +87% | +$1.6M | ﹤0.01% | 2669 |
|
|
2014
Q1 | $1.52M | Sell |
463,100
-114,000
| -20% | -$399K | ﹤0.01% | 4775 |
|
|
2013
Q4 | $1.92M | Sell |
577,100
-891,000
| -61% | -$2.59M | ﹤0.01% | 4342 |
|
|
2013
Q3 | $4.43M | Buy |
1,468,100
+264,200
| +22% | +$1.81M | ﹤0.01% | 2911 |
|
|
2013
Q2 | $9.85M | Buy |
+1,203,900
| New | +$9.19M | 0.01% | 1808 |
|
Susquehanna International Group's ACHN Position: Q1 2020 in Review
Susquehanna International Group sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 15,357 shares — an estimated $93K sold.
Susquehanna International Group first reported a position in ACHN in Q2 2013 and held it in 25 quarters. The position peaked at $6.83M in Q1 2015. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Susquehanna International Group reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Susquehanna International Group sold 15,357 Achillion Pharmaceuticals shares in Q1 2020, an estimated $93K.
- Susquehanna International Group first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 25 quarters.
- Susquehanna International Group's Achillion Pharmaceuticals position peaked at $6.83M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.